Not applicableStudy completedNCT05572645What this trial is testingPyrotinib Plus Trastuzumab Versus Pertuzumab Plus TrastuzumabWho this might be right forBreast Cancer Fudan University 333
Post-approval studies (Phase 4)UnknownNCT05131841What this trial is testingCipterbin Combined With Vinorelbine in the Treatment of HER2-positive MBCWho this might be right forMetastatic Breast Cancer Zhejiang Cancer Hospital 60
Testing effectiveness (Phase 2)Study completedNCT00191373What this trial is testingA Trial for HER2 Positive Breast Cancer Patients With Metastatic DiseaseWho this might be right forBreast NeoplasmsCancer of the BreastBreast Cancer Eli Lilly and Company 66
Testing effectiveness (Phase 2)UnknownNCT03204734What this trial is testingCapecitabine or Endocrinotherapy as a Maintenance Therapy Regimen at Least 2nd Line in Hormone Receptor Positive and HER2 Negative Metastatic Breast CancerWho this might be right forBreast Cancer Zhejiang Cancer Hospital 132
Not applicableStudy completedNCT05905939What this trial is testingHER2(Human Epidermal Growth Factor Receptor 2) -Positive Metastatic Breast Cancer in RussiaWho this might be right forBreast Cancer AstraZeneca 774
Testing effectiveness (Phase 2)Study completedNCT01565083What this trial is testingAssess Efficacy and Safety of Pertuzumab Given in Combination With Trastuzumab and Vinorelbine in Participants With Metastatic or Locally Advanced Human Epidermal Growth Factor Receptor (HER) 2-Positive Breast CancerWho this might be right forBreast Cancer Hoffmann-La Roche 213
Not applicableStudy completedNCT06975371What this trial is testingReal-World Outcomes of Patients With Metastatic Breast Cancer After Treatment With First-Line ET+CDK4/6iWho this might be right forAdvanced/Metastatic HER2-negative Breast Cancer Daiichi Sankyo 1,415
Testing effectiveness (Phase 2)WithdrawnNCT05191004What this trial is testingStudy of NUV-422 in Combination With Fulvestrant in Patients With HR+HER2- aBCWho this might be right forAdvanced Breast CancerMetastatic Breast CancerBreast Cancer+5 more Nuvation Bio Inc.
Not applicableActive Not RecruitingNCT03281902What this trial is testingGenetic Analysis in Blood and Tumor Samples From Patients With Advanced or Metastatic Estrogen Receptor Positive and HER2 Negative Breast Cancer Receiving Palbociclib and Endocrine TherapyWho this might be right forAdvanced Breast CarcinomaLocally Advanced Breast CarcinomaMetastatic Breast Carcinoma+6 more Mayo Clinic 68
Testing effectiveness (Phase 2)UnknownNCT05075512What this trial is testingThe Efficacy and Safety of Anlotinib Combined With Fulvestrant in Patients With Advanced Breast CancerWho this might be right forBreast Neoplasm Female Zhejiang Cancer Hospital 40
Testing effectiveness (Phase 2)Study completedNCT00347919What this trial is testingPazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Advanced Or Metastatic Breast CancerWho this might be right forNeoplasms, Breast GlaxoSmithKline 189
Testing effectiveness (Phase 2)Looking for participantsNCT04090567What this trial is testingOlaparib With Cediranib or AZD6738 for the Treatment of Advanced or Metastatic Germline BRCA Mutated Breast CancerWho this might be right forAdvanced Breast CarcinomaAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8+12 more M.D. Anderson Cancer Center 60
Early research (Phase 1)Ended earlyNCT05384119What this trial is testingPhase 1b/2 Study of TTI-101 in Combination for Patients With Metastatic Hormone Receptor-Positive and HER2-Negative Breast CancerWho this might be right forBreast Cancer Tvardi Therapeutics, Incorporated 6
Large-scale testing (Phase 3)Looking for participantsNCT07207070What this trial is testingA Randomised, Open-label, Multicentre Phase III Clinical Study to Evaluate the Efficacy and Safety of JS105 Combined With Dalpiciclib and Fulvestrant Compared With Dalpiciclib and Fulvestrant in Patients With PIK3CA-mutated, HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer.Who this might be right forBreast Cancer Risen (Suzhou) Pharma Tech Co., Ltd. 312
Testing effectiveness (Phase 2)Study completedNCT03530696What this trial is testingT-DM1 and Palbociclib for Metastatic HER2 Breast CancerWho this might be right forHER2-positive Breast CancerBreast CancerBreast Cancer Stage+3 more University of Arizona 55
Testing effectiveness (Phase 2)Study completedNCT01271920What this trial is testingCombination of AUY922 With Trastuzumab in HER2+ Advanced Breast Cancer Patients Previously Treated With TrastuzumabWho this might be right forAdvanced HER2-positive Breast Cancer Novartis Pharmaceuticals 45
Testing effectiveness (Phase 2)Study completedNCT01989780What this trial is testingBevacizumab Plus Paclitaxel Optimization Study With Interventional Aintenance Endocrine Therapy in Breast CancerWho this might be right forMetastatic Breast Cancer Japan Breast Cancer Research Group 160
Not applicableNot Yet RecruitingNCT07593196What this trial is testingHER2-positive Metastatic Breast Cancer in KazakhstanWho this might be right forMetastatic Breast Cancer AstraZeneca 240
Large-scale testing (Phase 3)Active Not RecruitingNCT05654623What this trial is testingLearn About a New Medicine Called Vepdegestrant (ARV-471, PF-07850327) in People Who Have Advanced Metastatic Breast CancerWho this might be right forAdvanced Breast Cancer Pfizer 624
Testing effectiveness (Phase 2)Ended earlyNCT02067741What this trial is testingCR1447 in Endocrine Responsive-HER2neg and TN-ARpos Breast CancerWho this might be right forMetastatic Breast AdenocarcinomaBreast Cancer Swiss Cancer Institute 29